PureTech Health (PRTC) Competitors $17.15 -0.10 (-0.58%) Closing price 08/11/2025 03:50 PM EasternExtended Trading$17.42 +0.27 (+1.57%) As of 04:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC vs. VCEL, APGE, TARS, ARQT, SPRY, IMCR, ADPT, SRPT, EWTX, and BHVNShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Vericel (VCEL), Apogee Therapeutics (APGE), Tarsus Pharmaceuticals (TARS), Arcutis Biotherapeutics (ARQT), ARS Pharmaceuticals (SPRY), Immunocore (IMCR), Adaptive Biotechnologies (ADPT), Sarepta Therapeutics (SRPT), Edgewise Therapeutics (EWTX), and Biohaven (BHVN). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Its Competitors Vericel Apogee Therapeutics Tarsus Pharmaceuticals Arcutis Biotherapeutics ARS Pharmaceuticals Immunocore Adaptive Biotechnologies Sarepta Therapeutics Edgewise Therapeutics Biohaven Vericel (NASDAQ:VCEL) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership. Do analysts prefer VCEL or PRTC? Vericel presently has a consensus price target of $60.33, indicating a potential upside of 70.29%. PureTech Health has a consensus price target of $45.00, indicating a potential upside of 162.39%. Given PureTech Health's stronger consensus rating and higher probable upside, analysts plainly believe PureTech Health is more favorable than Vericel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vericel 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media favor VCEL or PRTC? In the previous week, Vericel had 6 more articles in the media than PureTech Health. MarketBeat recorded 7 mentions for Vericel and 1 mentions for PureTech Health. Vericel's average media sentiment score of 0.54 beat PureTech Health's score of 0.00 indicating that Vericel is being referred to more favorably in the media. Company Overall Sentiment Vericel Positive PureTech Health Neutral Is VCEL or PRTC more profitable? Vericel has a net margin of 2.85% compared to PureTech Health's net margin of 0.00%. Vericel's return on equity of 2.47% beat PureTech Health's return on equity.Company Net Margins Return on Equity Return on Assets Vericel2.85% 2.47% 1.69% PureTech Health N/A N/A N/A Do institutionals and insiders have more ownership in VCEL or PRTC? 0.0% of PureTech Health shares are owned by institutional investors. 7.2% of Vericel shares are owned by company insiders. Comparatively, 5.3% of PureTech Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation & earnings, VCEL or PRTC? PureTech Health has lower revenue, but higher earnings than Vericel. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVericel$237.22M7.54$10.36M$0.12295.25PureTech Health$4.83M85.68$27.78MN/AN/A Which has more risk and volatility, VCEL or PRTC? Vericel has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. SummaryVericel beats PureTech Health on 9 of the 15 factors compared between the two stocks. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$416.27M$3.00B$5.48B$9.72BDividend YieldN/A2.28%4.59%4.13%P/E RatioN/A17.0529.7724.63Price / Sales85.68347.15453.22102.60Price / Cash7.2440.7324.8127.99Price / Book1.018.898.595.76Net Income$27.78M-$54.75M$3.26B$264.95M7 Day Performance-7.70%-2.71%-0.32%-0.01%1 Month Performance-2.56%4.43%2.14%1.27%1 Year Performance-24.25%19.64%44.52%26.11% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health1.451 of 5 stars$17.15-0.6%$45.00+162.4%-19.7%$416.27M$4.83M0.00100High Trading VolumeVCELVericel2.104 of 5 stars$37.58+5.5%$59.86+59.3%-22.3%$1.80B$237.22M313.19300APGEApogee Therapeutics2.5806 of 5 stars$37.24-1.4%$99.00+165.8%-14.4%$1.74BN/A-10.3491News CoveragePositive NewsEarnings ReportAnalyst ForecastTARSTarsus Pharmaceuticals2.4501 of 5 stars$41.91+2.7%$66.67+59.1%+86.5%$1.71B$182.95M-15.3550Earnings ReportAnalyst RevisionARQTArcutis Biotherapeutics2.703 of 5 stars$14.52+1.6%$19.40+33.6%+46.1%$1.70B$196.54M-13.96150Earnings ReportAnalyst UpgradeAnalyst RevisionSPRYARS Pharmaceuticals3.2591 of 5 stars$17.38+1.2%$31.00+78.4%+50.6%$1.69B$97.12M-108.6290Upcoming EarningsIMCRImmunocore1.8459 of 5 stars$32.53-1.4%$58.89+81.0%-14.3%$1.66B$310.20M-75.65320Earnings ReportAnalyst DowngradeADPTAdaptive Biotechnologies2.9973 of 5 stars$10.91+5.6%$11.33+3.9%+171.8%$1.57B$178.96M-11.36790Earnings ReportSRPTSarepta Therapeutics4.6132 of 5 stars$17.10+7.5%$49.12+187.3%-85.7%$1.56B$1.90B-6.361,372Trending NewsEarnings ReportAnalyst UpgradeGap DownEWTXEdgewise Therapeutics2.0052 of 5 stars$13.61-4.9%$40.55+197.9%-21.0%$1.51BN/A-8.7860Earnings ReportAnalyst RevisionBHVNBiohaven2.365 of 5 stars$14.70-0.1%$58.46+297.8%-65.5%$1.50BN/A-1.57239Trending NewsEarnings Report Related Companies and Tools Related Companies VCEL Alternatives APGE Alternatives TARS Alternatives ARQT Alternatives SPRY Alternatives IMCR Alternatives ADPT Alternatives SRPT Alternatives EWTX Alternatives BHVN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTC) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredSell these stocks now—what to buy insteadWall Street veteran Marc Chaikin—creator of the Power Gauge system—is warning that “smart money” is rapidly pu...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access